Russian court seizes $13m from JPMorgan, Commerzbank    Germany's March '24 manufacturing orders dip 0.4%    EGP stable against USD in Tuesday early trade    Amazon to invest $8.88b into Singapore cloud infrastructure    Asian shares hit 15-m high on US rate cut bets    State-run exchange offices accumulate EGP 22.3bn in foreign currencies post-flotation    Egypt leads MENA surge as Bitget Wallet sees 300% growth    Health Ministry on high alert during Easter celebrations    Egypt's Communications Ministry, Xceed partner on AI call centre tool    Egypt warns of Israeli military operation in Rafah    US academic groups decry police force in campus protest crackdowns    US Military Official Discusses Gaza Aid Challenges: Why Airdrops Aren't Enough    US Embassy in Cairo announces Egyptian-American musical fusion tour    Chubb prepares $350M payout for state of Maryland over bridge collapse    Egypt, France emphasize ceasefire in Gaza, two-state solution    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    Health Minister, Johnson & Johnson explore collaborative opportunities at Qatar Goals 2024    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Trump is back, still not conceding defeat, trumpets vaccine progress
Published in Ahram Online on 14 - 11 - 2020

Gliding over significant challenges still to come, President Donald Trump offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. He still did not concede the election.
Trump spoke from the the Rose Garden Friday as the nation sets records for confirmed cases of COVID-19, and as hospitalizations near critical levels and fatalities climb to the highest levels since the spring. He said a vaccine would ship in ``a matter of weeks`` to vulnerable populations, though the Food and Drug Administration has not yet been asked to grant the necessary emergency approvals.
Public health experts worry that Trump's refusal to take aggressive action on the pandemic or to coordinate with the Biden team during the final two months of his presidency will only worsen the effects of the virus and hinder the nation's ability to swiftly distribute a vaccine next year.
As states impose new restrictions in the face of rising caseloads, Trump asked all Americans to remain ``vigilant.`` But he ruled out a nationwide ``lockdown`` and appeared to acknowledge that the decision won't be his much longer.
``This administration will not be going to a lockdown,'' he said. ``Hopefully whatever happens in the future, who knows, which administration it will be I guess time will tell, but I can tell you this administration will not go to a lockdown.''
Biden, for his part, has not endorsed a nationwide shutdown, but he appealed for Trump to take ``urgent action'' to curtail the spread of the virus. ``The crisis does not respect dates on the calendar, it is accelerating right now,'' he said in a statement Friday.
Trump said vaccines would ``arrive within a few weeks,'' saying they were ready and merely awaiting approval _ and would be given ``to high-risk individuals right away.'' In fact, there's no guarantee that Pfizer's shot, the front-runner, will get rapid authorization for emergency use. Even if it does, there's no information yet indicating if the vaccine works in older adults or just younger, healthier adults. Nor does Pfizer have a large commercial stockpile already poised to ship; initial batches of shots would be small and targeted to certain still-to-be-determined populations.
Trump took no questions Friday from reporters. He hasn't answered questions since before Election Day.
Meanwhile, his campaign prediction that the U.S. was ``rounding the turn'' on the pandemic has met a harsh reality, with his own White House becoming the focus of yet another outbreak.
Trump's aggressive travel despite the virus has taken its toll on his protectors as well. The U.S. Secret Service is experiencing a significant number of cases, many believed to be linked to his rallies in the closing days of the campaign, according to one official.
White House press secretary Kayleigh McEnany, meanwhile, said Trump is ``not even at that point yet'' when it comes to conceding to Biden. Trump has leveled baseless allegations of widespread voter fraud, even as his own administration has said there is no evidence to support the claims. His aides suggest he is merely trying to keep his base of supporters on his side in defeat.
Trump spoke with conservative media on Friday, including Fox News' Geraldo Rivera, suggesting he would acknowledge the loss only after exhausting his legal options.
``You know, he told me he was a realist,`` Rivera said. ``He told me he would do the right thing.''
With more than 100,000 new confirmed U.S. cases reported daily for more than a week, Trump has been more focused on tracking the rollout of a vaccine, which won't be widely available for months. He has fumed that Pfizer intentionally withheld an announcement about progress on its vaccine trial until after Election Day, according to a White House official who was not authorized to publicly comment and spoke on condition of anonymity. Pfizer itself did not receive the preliminary results from its independent study monitors until that group met five days after the election.
Dr. Moncef Slaoui, head of Operation Warp Speed, the effort to get a vaccine to market as speedily and safely as possible, vouched for the safety of the vaccines in development. ``While we are not there yet, we are close to the objective'' to having a vaccine ready for deployment by the end of the year, he said.
Trump, aiming to settle political scores, said he would not ship vaccines to hard-hit New York until Democratic Gov. Andrew Cuomo signs off, noting that the state has promised to do its own review to ensure their safety. ``The governor will let us know when he's ready,`` Trump said.
Cuomo in a CNN interview pushed back, saying New York is one of several states that set up their own scientific panels to give residents greater confidence to take the vaccine if it is safe to use. He accused Trump of ``politicizing the process.`` Sixty-two percent of respondents in a September Kaiser Family Foundation poll said they are at least somewhat worried that political pressure from the Trump administration would lead to the FDA rushing to approve a vaccine without making sure that it is safe.
``As soon as they get us the drug, we are ready to distribute it,`` Cuomo said.
The president has consistently played down the pandemic, which has killed more than 240,000 Americans and infected more than 10 million people in the U.S.
White House chief of staff Mark Meadows tested positive last week after attending an election night party at the White House. Others at the party also have tested positive, including White House political director Brian Jack, former White House aide Healy Baumgardner and Trump campaign advisers David Bossie and Corey Lewandowski. Lewandowski said Thursday that he believes he contracted the virus in Philadelphia while assisting the president's election challenge there.
Biden, for his part, largely framed the election as a referendum on Trump's handling of the pandemic. He has made addressing the virus his top priority as he moves forward with his transition. He spoke by phone Thursday with House Speaker Nancy Pelosi and Senate Minority Leader Chuck Schumer about the intensifying pandemic and prospects for passage of a COVID-19 relief bill in the lame duck session of Congress.
Incoming White House chief of staff Ron Klain said Biden will appoint a ``COVID coordinator'' who will lead the administration's pandemic response. Klain, speaking on MSNBC Thursday night, said the individual will have ``direct access'' to the president and will brief him daily on the pandemic. A team of people underneath the coordinator will supervise vaccine distribution, address supply chain disruptions and improve access to testing.


Clic here to read the story from its source.